ChangSSBochnerBHChouRet al. Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary. J Oncol Pract2017;13(9):621-5.
2.
WalkerMDoironRCFrenchSDet al. Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers. Clin Oncol2017; 29 818-26.
3.
Jereczek-FossaBAColomboRMagnaniTet al. Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy. Tumori2015;101(2):174-8.
4.
ArcangeliGArcangeliSStrigariL.A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC). Crit Rev Oncol Hematol2015;94(1):105-15.
5.
GiacaloneNJShipleyWUClaymanRHet al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol2017; 71(6):952-60.
6.
WeissCWittlingerMEngehausenDGet al. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy. Int J Radiat Oncol Biol Phys2008;70:1502-6.
7.
ZietmanALGrocelaJZehrEet al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology2001;58:380-5.
8.
RodelCGrabenbauerCGKuhnRet al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol2002; 20: 3061-71.
9.
RamaniVAMaddineniSBGreyBRClarkeNW.Differential complication rates following radical cystectomy in the irradiated and non-irradiated pelvis. Eur Urol2010; 57: 1058-63.
10.
BouchnerBHFigueroaAJSkinnerECet al. Salvage radical cistoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol1998; 160:29-33.
11.
ZietmanALSaccoDSkowronskiUet al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors. J Urol2003; 170:1772-6.
12.
JamesNDHussainSAHallEet al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med2012;366:1477-88.
13.
ArcangeliGStrigariLArcangeliS.Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials. Crit Rev Oncol Hematol2015;95(3):387-96.
14.
RoseTLDealAMLadoireSet al. Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer. Bladder Cancer2016;2(4):405-13.
15.
VashisthaVWangHMazzoneAet al. Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys2017;97(5):1002-20.
16.
CaffoOThompsonCDe SantisMet al. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. Radiother Oncol2016;121(2):193-8.
17.
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol2005. 48: 202-5.
18.
KrageljBZaletel-KrageljLSedmakBCuferTCervekJ.Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer. Radiother Oncol2005;75:44-7.
19.
Advanced Bladder Cancer Overview Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer. Chichester, UK: John Wiley & Sons, Ltd.; 2008 (Cochrane Library; Issue 2), 〈Available at http://www.uptdate-software.com〉.
20.
ShipleyWUKaufmanDSZehrEet al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology2002; 60:62-7.
21.
KachnicLAKaufmanDSHeneyNMet al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol1997;15:1022-9.
22.
PloussardGDaneshmandSEfstathiouJAet al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol2014;66(1):120-37.
23.
GakisGEfstathiouJLernerSPet al. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol2013;63:45-57.
